CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 36912-37191 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T214","span":{"begin":0,"end":279},"obj":"Sentence"},{"id":"T69584","span":{"begin":0,"end":279},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interestingly, the known GSK-3 inhibitors i.e. bisindol-maleimides (115) [83] and hymenialdisine (116) [84] (Fig. 9) contain the moieties structurally similar to the pyrazolone scaffold, which indicated the reasonability of using pyrazolone for the design of the GSK-3 inhibitor."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T214","span":{"begin":0,"end":279},"obj":"Sentence"}],"text":"Interestingly, the known GSK-3 inhibitors i.e. bisindol-maleimides (115) [83] and hymenialdisine (116) [84] (Fig. 9) contain the moieties structurally similar to the pyrazolone scaffold, which indicated the reasonability of using pyrazolone for the design of the GSK-3 inhibitor."}